Providing market intelligence for more than 35 years

In The News

8% of UK broadband homes own a smart watch

European research from Parks Associates shows 8 per cent of UK broadband households have at least one smart watch. These wearables, which can connect to the Internet, create new health, mobile payment, and smart home opportunities for companies in the IoT ecosystem, according to the firm’s consumer research project Connected Consumer in Europe.

“The IoT concept is so all encompassing it is easy to miss its practical implications for specific markets, industry players, and consumers,” said Jennifer Kent, Director, Research Quality & Product Development, Parks Associates. “Consumer IoT is all about the connected lifestyle, which is expanding beyond smartphones in a meaningful way, creating new applications for people to live independently and monitor their health.”

From the article "8% of UK broadband homes own a smart watch" by Advanced Television.

Previously In The News

15 Percent of U.S. Broadband Households Plan to Buy Wireless Speakers

A recent Parks Research study found that, of U.S. broadband households, 18 percent plan to buy earbuds over the next 12 months, 16 percent plan to buy headphones, and 15 percent plan to buy wireless s...

Cord Cutters Face A Sea Of Streaming Options

Hartstein’s decision was made easier because of a flood of Internet streaming services that allows consumers to cobble together their own video packages. There are more than 100 Internet video service...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...